Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01178333 · ClinicalTrials.gov registry record
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
A clinical trial, sponsored by Carelon Research.
- Completed
- Registry status
- 668
- Enrollment target
NCT01178333: Completed study, sponsored by Carelon Research.
NCT01178333 is a clinical trial that has completed, run by Carelon Research. The registered enrollment target is 668 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01178333 has completed, sponsored by Carelon Research.
- COMPLETED
- Registry status
- 668 participants
- Enrollment target
Study Summary
HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in the patients' medical records. Information about laboratory values (such as platelet counts), treatments (such as medications), and outcomes (such as blood clots, amputation, and death) will be included.
Primary Outcome
The mean time to an event is estimated by the area under the survival function. If the largest time is an event time, then the survival function goes to zero at that time, and the mean survival estimate is finite. Otherwise, the mean time cannot be estimated and may lead to a bias.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 668 participants |
| Start Date | 2010-06 |
| Est. Completion | 2010-12 |
What the finished NCT01178333 record still lists
NCT01178333 is an observational study that tracks outcomes without assigning an intervention. The registered 668 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01178333 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01178333 about?
NCT01178333 is a clinical study titled "Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study". HIT-RADIO is a study of patients who had a positive heparin PF-4 antibody test between 1/21/2008 and 9/25/2008 at selected hospitals. The study will collect and analyse information that is already in the patients' medical records. Information about laboratory values (such as platelet counts), treatm...
What is the current status of trial NCT01178333?
This trial is currently completed. The enrollment target is 668 participants. The study started on 2010-06. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01178333?
This trial is sponsored by Carelon Research, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04155034 · 668 participants · Phase 3
S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Radiation Affects Lifespan in Patients With Small Cell Lung Cancer
- NCT04179981 · 668 participants · NA
Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)
- NCT05006482 · 668 participants · Phase 3
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
- NCT02984761 · 670 participants · NA
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia